Sfoglia per Autore
Immunohistochemical Markers and TILs Evaluation for Endometrial Carcinoma
2022-01-01 Bounous, Valentina Elisabetta; Ferrero, Annamaria; Campisi, Paola; Fuso, Luca; Pezua Sanjinez, Jeremy Oscar Smith; Manassero, Sabrina; De Rosa, Giovanni; Biglia, Nicoletta
Predicting Response to Anthracyclines in Ovarian Cancer
2022-01-01 Ferrero A.; Borghese M.; Restaino S.; Puppo A.; Vizzielli G.; Biglia N.
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic
2021-01-01 COVIDSurg Collaborative; Ferrero A
Is it time to include [18F]FDG-PET/CT in the diagnostic work-up for lymph node staging in cN0 vulvar cancer patients?
2021-01-01 Aide N; Markovina S; Ferrero A
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic
2021-01-01 STARSurg Collaborative and COVIDSurg Collaborative; Ferrero A
The Search for New 2-18F-FDG PET/CT Imaging Biomarkers in Advanced Ovarian Cancer Patients: Focus on Peritoneal Staging for Guiding Precision Medicine and Management Decisions
2021-01-01 Delgado Bolton RC; Calapaquí Terán AK; Pellet O; Ferrero A; Giammarile F
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
2021-01-01 COVIDSurg Collaborative; Ferrero A
Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study
2021-01-01 Daniele G; Raspagliesi F; Scambia G; Pisano C; Colombo N; Frezzini S; Tognon G; Artioli G; Gadducci A; Lauria R; Ferrero A; Cinieri S; De Censi A; Breda E; Scollo P; De Giorgi U; Lissoni AA; Katsaros D; Lorusso D; Salutari V; Cecere SC; Zaccarelli E; Nardin M; Bogani G; Distefano M; Greggi S; Piccirillo MC; Fossati R; Giannone G; Arenare L; Gallo C; Perrone F; Pignata S
Could a 2D/3DUSbased model be helpful in the assessment of myometrial invasion at time of intraoperative frozen section? Apilot study
2021-01-01 Ferrero A.; Novara L.; Perotto S.; Capece R.; Petey F.; Perrini G.; Mariani L.L.; Derosa G.; Biglia N.; Fuso L.
Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial
2021-01-01 Di Liello R; Arenare L; Raspagliesi F; Scambia G; Pisano C; Colombo N; Frezzini S; Tognon G; Artioli G; Gadducci A; Lauria R; Ferrero A; Cinieri S; De Censi A; Breda E; Scollo P; De Giorgi U; Lissoni AA; Katsaros D; Lorusso D; Salutari V; Cecere SC; Lapresa M; Nardin M; Bogani G; Distefano M; Greggi S; Gargiulo P; Schettino C; Gallo C; Daniele G; Califano D; Perrone F; Pignata S; Piccirillo MC.
The systemic treatment of recurrent ovarian cancer revisited
2021-01-01 Baert T; Ferrero A; Sehouli J; O'Donnell DM; González-Martín A; Joly F; van der Velden J; Blecharz P; Tan DSP; Querleu D; Colombo N; du Bois A; Ledermann JA
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study
2021-01-01 Glasbey JC; Nepogodiev D; Simoes JFF; Omar O; Li E; Venn ML; Pgdme; Abou Chaar MK; Capizzi V; Chaudhry D; Desai A; Edwards JG; Evans JP; Fiore M; Videria JF; Ford SJ; Ganly I; Griffiths EA; Gujjuri RR; Kolias AG; Kaafarani HMA; Minaya-Bravo A; McKay SC; Mohan HM; Roberts KJ; San Miguel-Méndez C; Pockney P; Shaw R; Smart NJ; Stewart GD; Sundar Mrcog S; Vidya R; Bhangu AA. COVIDSurg Collaborative; Ferrero A
EANM guideline on the role of 2-[18F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA)
2021-01-01 Delgado Bolton RC; Aide N; Colletti PM; Ferrero A; Paez D; Skanjeti A; Giammarile F
Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature
2021-01-01 Giannone G.; Scotto G.; Katsaros D.; De Giorgi U.; Farolfi A.; Borella F.; Cosma S.; Ferrero A.; Mangiacotti S.; Villa M.; Tuninetti V.; Ghisoni E.; Turinetto M.; Mittica G.; Gemmiti S.; Zavallone L.; Aglietta M.; Pasini B.; Di Maio M.; Valabrega G.
Laparoscopic radical hysterectomy: a European Society of Gynaecological Oncology (ESGO) statement
2020-01-01 Querleu D; Cibula D; Concin N; Fagotti A; Ferrero A; Fotopoulou C; Knapp P; Kurdiani D; Ledermann JA; Mirza MR; Morice P; Ponce J; Van der Steen-Banasik E; Taskiran C; Wimberger P; Zalewski K; Sessa C
Report from the 21st meeting of the European Society of Gynaecological Oncology (ESGO 2019)
2020-01-01 Bizzarri N; Razumova Z; Selcuk I; Taumberger N; Nikolova T; Fotopoulou C; Van der Steen-Banasik E; Ferrero A; Zalewski K
SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer
2020-01-01 Chiva L; Zanagnolo V; Querleu D; Martin-Calvo N; Arévalo-Serrano J; Căpîlna ME; Fagotti A; Kucukmetin A; Mom C; Chakalova G; Aliyev S; Malzoni M; Narducci F; Arencibia O; Raspagliesi F; Toptas T; Cibula D; Kaidarova D; Meydanli MM; Tavares M; Golub D; Perrone AM; Poka R; Tsolakidis D; Vujić G; Jedryka MA; Zusterzeel PLM; Beltman JJ; Goffin F; Haidopoulos D; Haller H; Jach R; Yezhova I; Berlev I; Bernardino M; Bharathan R; Lanner M; Maenpaa MM; Sukhin V; Feron JG; Fruscio R; Kukk K; Ponce J; Minguez JA; Vázquez-Vicente D; Castellanos T; Chacon E; Alcazar JL; SUCCOR study Group: Abdalla N; Akgöl S; Aksahin D; Aliyev S; Alonso-Espias M; Aluloski I; Andrade C; Badzakov N; Barrachina R; Bogani G; Bonci E-A; Bonsang-Kitzis H; Brucker C; Cárdenas L; Casajuana A; Cavalle P; Cea J; Chiofalo B; Cordeiro G; Coronado P; Cuadra M; Díez J; Diniz da Costa T; Domingo S; Dostalek L; Elif F; Erasun D; Fehr M; Fernandez-Gonzalez S; Ferrero A; Fidalgo S; Fiol G; Galaal K; García J; Gebauer G; Ghezzi F; Gilabert J; Gomes N; Gonçalves E; Gonzalez V; Grandjean F; Guijarro M; Guyon F; Haesen J; Hernandez-Cortes G; Herrero S; Pete I; Kalogiannidis I; Karaman E; Kavallaris A; Klasa L; Kotsopoulos I; Stefan Kovachev S; Leht U A; Lekuona A; Luyckx M; Mallmann M; Mancebo G; Mandic A; Marina T; Martin V; Martín-Salamanca M B; Lago V; Martinez A; Meili G; Mendinhos G; Mereu L; Mitrovic M; Morales S; Moratalla E; Gómez-Hidalgo N R; Morillas B; Myriokefalitaki E; PakižImre M; Pete I; Petousis S; Pirtea L; Povolotskaya N; Prader S; Quesada A; Redecha M; Roldan F; Rolland P; Saaron R; Sarac C-P; Scharf J-P; Smrkolj S; Sousa R; Stepanyan A; Študent V; Tauste C; Trum H; Turan T; Undurraga M; Vázquez A; Vergote I; Vorgias G; and Zapardiel I
Impact of Bevacizumab-containing Primary Treatment on Outcome of Recurrent Ovarian Cancer: An Italian Study
2020-01-01 Gadducci A; Cosio S; Lissoni AA; Zizioli V; Adorni M; Ferrero A; Landoni F; Sartori E
Clinical pathways of recovery after surgery for advanced ovarian/tubal/peritoneal cancer: An NSGO-MaNGO international survey in collaboration with AGO - A focus on surgical aspects
2019-01-01 Piovano E.; Ferrero A.; Zola P.; Marth C.; Mirza M.R.; Lindemann K.
Predictors of extensive lymphatic dissemination and recurrences in node-positive endometrial cancer
2019-01-01 Zanfagnin V.; Huang Y.; Mc Gree M.E.; Weaver A.L.; Casarin J.; Multinu F.; Cappuccio S.; Ferrero A; Mariani A.; Glaser G.E.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Immunohistochemical Markers and TILs Evaluation for Endometrial Carcinoma | 2022 | Bounous, Valentina Elisabetta; Ferrero, Annamaria; Campisi, Paola; Fuso, Luca; Pezua Sanjinez, Jeremy Oscar Smith; Manassero, Sabrina; De Rosa, Giovanni; Biglia, Nicoletta | |
| Predicting Response to Anthracyclines in Ovarian Cancer | 2022 | Ferrero A.; Borghese M.; Restaino S.; Puppo A.; Vizzielli G.; Biglia N. | |
| Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic | 2021 | COVIDSurg Collaborative; Ferrero A | |
| Is it time to include [18F]FDG-PET/CT in the diagnostic work-up for lymph node staging in cN0 vulvar cancer patients? | 2021 | Aide N; Markovina S; Ferrero A | |
| Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic | 2021 | STARSurg Collaborative and COVIDSurg Collaborative; Ferrero A | |
| The Search for New 2-18F-FDG PET/CT Imaging Biomarkers in Advanced Ovarian Cancer Patients: Focus on Peritoneal Staging for Guiding Precision Medicine and Management Decisions | 2021 | Delgado Bolton RC; Calapaquí Terán AK; Pellet O; Ferrero A; Giammarile F | |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study | 2021 | COVIDSurg Collaborative; Ferrero A | |
| Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study | 2021 | Daniele G; Raspagliesi F; Scambia G; Pisano C; Colombo N; Frezzini S; Tognon G; Artioli G; Gadducci A; Lauria R; Ferrero A; Cinieri S; De Censi A; Breda E; Scollo P; De Giorgi U; Lissoni AA; Katsaros D; Lorusso D; Salutari V; Cecere SC; Zaccarelli E; Nardin M; Bogani G; Distefano M; Greggi S; Piccirillo MC; Fossati R; Giannone G; Arenare L; Gallo C; Perrone F; Pignata S | |
| Could a 2D/3DUSbased model be helpful in the assessment of myometrial invasion at time of intraoperative frozen section? Apilot study | 2021 | Ferrero A.; Novara L.; Perotto S.; Capece R.; Petey F.; Perrini G.; Mariani L.L.; Derosa G.; Biglia N.; Fuso L. | |
| Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial | 2021 | Di Liello R; Arenare L; Raspagliesi F; Scambia G; Pisano C; Colombo N; Frezzini S; Tognon G; Artioli G; Gadducci A; Lauria R; Ferrero A; Cinieri S; De Censi A; Breda E; Scollo P; De Giorgi U; Lissoni AA; Katsaros D; Lorusso D; Salutari V; Cecere SC; Lapresa M; Nardin M; Bogani G; Distefano M; Greggi S; Gargiulo P; Schettino C; Gallo C; Daniele G; Califano D; Perrone F; Pignata S; Piccirillo MC. | |
| The systemic treatment of recurrent ovarian cancer revisited | 2021 | Baert T; Ferrero A; Sehouli J; O'Donnell DM; González-Martín A; Joly F; van der Velden J; Blecharz P; Tan DSP; Querleu D; Colombo N; du Bois A; Ledermann JA | |
| Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study | 2021 | Glasbey JC; Nepogodiev D; Simoes JFF; Omar O; Li E; Venn ML; Pgdme; Abou Chaar MK; Capizzi V; Chaudhry D; Desai A; Edwards JG; Evans JP; Fiore M; Videria JF; Ford SJ; Ganly I; Griffiths EA; Gujjuri RR; Kolias AG; Kaafarani HMA; Minaya-Bravo A; McKay SC; Mohan HM; Roberts KJ; San Miguel-Méndez C; Pockney P; Shaw R; Smart NJ; Stewart GD; Sundar Mrcog S; Vidya R; Bhangu AA. COVIDSurg Collaborative; Ferrero A | |
| EANM guideline on the role of 2-[18F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA) | 2021 | Delgado Bolton RC; Aide N; Colletti PM; Ferrero A; Paez D; Skanjeti A; Giammarile F | |
| Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature | 2021 | Giannone G.; Scotto G.; Katsaros D.; De Giorgi U.; Farolfi A.; Borella F.; Cosma S.; Ferrero A.; Mangiacotti S.; Villa M.; Tuninetti V.; Ghisoni E.; Turinetto M.; Mittica G.; Gemmiti S.; Zavallone L.; Aglietta M.; Pasini B.; Di Maio M.; Valabrega G. | |
| Laparoscopic radical hysterectomy: a European Society of Gynaecological Oncology (ESGO) statement | 2020 | Querleu D; Cibula D; Concin N; Fagotti A; Ferrero A; Fotopoulou C; Knapp P; Kurdiani D; Ledermann JA; Mirza MR; Morice P; Ponce J; Van der Steen-Banasik E; Taskiran C; Wimberger P; Zalewski K; Sessa C | |
| Report from the 21st meeting of the European Society of Gynaecological Oncology (ESGO 2019) | 2020 | Bizzarri N; Razumova Z; Selcuk I; Taumberger N; Nikolova T; Fotopoulou C; Van der Steen-Banasik E; Ferrero A; Zalewski K | |
| SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer | 2020 | Chiva L; Zanagnolo V; Querleu D; Martin-Calvo N; Arévalo-Serrano J; Căpîlna ME; Fagotti A; Kucukmetin A; Mom C; Chakalova G; Aliyev S; Malzoni M; Narducci F; Arencibia O; Raspagliesi F; Toptas T; Cibula D; Kaidarova D; Meydanli MM; Tavares M; Golub D; Perrone AM; Poka R; Tsolakidis D; Vujić G; Jedryka MA; Zusterzeel PLM; Beltman JJ; Goffin F; Haidopoulos D; Haller H; Jach R; Yezhova I; Berlev I; Bernardino M; Bharathan R; Lanner M; Maenpaa MM; Sukhin V; Feron JG; Fruscio R; Kukk K; Ponce J; Minguez JA; Vázquez-Vicente D; Castellanos T; Chacon E; Alcazar JL; SUCCOR study Group: Abdalla N; Akgöl S; Aksahin D; Aliyev S; Alonso-Espias M; Aluloski I; Andrade C; Badzakov N; Barrachina R; Bogani G; Bonci E-A; Bonsang-Kitzis H; Brucker C; Cárdenas L; Casajuana A; Cavalle P; Cea J; Chiofalo B; Cordeiro G; Coronado P; Cuadra M; Díez J; Diniz da Costa T; Domingo S; Dostalek L; Elif F; Erasun D; Fehr M; Fernandez-Gonzalez S; Ferrero A; Fidalgo S; Fiol G; Galaal K; García J; Gebauer G; Ghezzi F; Gilabert J; Gomes N; Gonçalves E; Gonzalez V; Grandjean F; Guijarro M; Guyon F; Haesen J; Hernandez-Cortes G; Herrero S; Pete I; Kalogiannidis I; Karaman E; Kavallaris A; Klasa L; Kotsopoulos I; Stefan Kovachev S; Leht U A; Lekuona A; Luyckx M; Mallmann M; Mancebo G; Mandic A; Marina T; Martin V; Martín-Salamanca M B; Lago V; Martinez A; Meili G; Mendinhos G; Mereu L; Mitrovic M; Morales S; Moratalla E; Gómez-Hidalgo N R; Morillas B; Myriokefalitaki E; PakižImre M; Pete I; Petousis S; Pirtea L; Povolotskaya N; Prader S; Quesada A; Redecha M; Roldan F; Rolland P; Saaron R; Sarac C-P; Scharf J-P; Smrkolj S; Sousa R; Stepanyan A; Študent V; Tauste C; Trum H; Turan T; Undurraga M; Vázquez A; Vergote I; Vorgias G; and Zapardiel I | |
| Impact of Bevacizumab-containing Primary Treatment on Outcome of Recurrent Ovarian Cancer: An Italian Study | 2020 | Gadducci A; Cosio S; Lissoni AA; Zizioli V; Adorni M; Ferrero A; Landoni F; Sartori E | |
| Clinical pathways of recovery after surgery for advanced ovarian/tubal/peritoneal cancer: An NSGO-MaNGO international survey in collaboration with AGO - A focus on surgical aspects | 2019 | Piovano E.; Ferrero A.; Zola P.; Marth C.; Mirza M.R.; Lindemann K. | |
| Predictors of extensive lymphatic dissemination and recurrences in node-positive endometrial cancer | 2019 | Zanfagnin V.; Huang Y.; Mc Gree M.E.; Weaver A.L.; Casarin J.; Multinu F.; Cappuccio S.; Ferrero A; Mariani A.; Glaser G.E. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile